Pharmacotherapy for social anxiety disorder: an update.
Michael Van Ameringen, Catherine Mancini, Beth Patterson, William Simpson
Department of Psychiatry and Behavioural Neurosciences, McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada. vanamer@mcmaster.ca
The Israel journal of psychiatry and related sciences 2009Since the emergence of social phobia into the diagnostic nomenclature, we have seen an exponential expansion in our knowledge regarding effective treatment of this disorder. The literature clearly supports the use of SSRIs and the SNRI venlafaxine ER as first line pharmacological agents in the treatment of GSAD. In this article, treatment studies of pharmacotherapy of social phobia are summarized. Additional issues such as comparative efficacy, treatment resistance and relapse-prevention are reviewed.
Citation
Michael Van Ameringen, Catherine Mancini, Beth Patterson, William Simpson. Pharmacotherapy for social anxiety disorder: an update. The Israel journal of psychiatry and related sciences. 2009;46(1):53-61
Mesh Tags
Substances
PMID: 19728573
View Full Text
